We are making a handful of more trades Tuesday. Selling 75 shares of GE Healthcare at roughly $86 each; following the trade, Jim Cramer’s Charitable Trust will own 550 shares of GEHC, decreasing its weighting to about 1.43% from about 1.62% We are buying 50 shares of TJX at roughly $116; following the trade, the Trust will own 800 shares of TJX, increasing its weighting to 2.75% from about 2.6% We are buying 50 shares of Texas Roadhouse at roughly $176; following the trade, the Trust will own 400 shares of TXRH, increasing its weighting to 2.10% from 1.84% We’re putting more cash to work following the sharp market declines over tariff uncertainty. President Donald Trump stepped things up Tuesday, announcing he’s increasing tariffs on Canadian steel and aluminum to 50% from 25%. The move is slated to go into effect Wednesday morning. Despite the oversold nature of the market, according to the S & P 500 Short Range Oscillator , we’re booking some profits in GE Healthcare. This sale is similar to our repositioning trims of Abbott Laboratories and Bristol Myers Squibb into strength over the past few sessions. The market has crowded into health care and other defensive stocks due to fears about the economy, and we want to be careful about chasing these moves. Our concern is that the rotation could flip back if we see improving economic data or easing trade policy. GEHC 1Y mountain GE Healthcare 1 year Shares of GEHC are one of the rare winners in another ugly tape, rallying after analysts at Goldman Sachs raised their rating to a buy and increased their price target to $100 per share. The key part of Goldman’s now bullish thesis is an incrementally more positive outlook on China hospital capital expenditures. This is a very encouraging update from Goldman, but GEHC has already been nicely outperforming the S & P 500 year to date. The stock is up about 11% against a 5% decline in the S & P 500, and we don’t want to give back that outperformance. From this sale, we will realize a solid gain of about 25% on stock purchased in August 2023. We’ll use the cash proceeds from GEHC and dip into our cash position to make two buys: TJX Companies and Texas Roadhouse. This aligns with our discipline to buy when the Oscillator flashes oversold. TJX 1Y mountain TJX Companies 1 year TJX reported a fantastic quarter a couple of weeks ago with a strong same-store sales and earnings per share beat. The stock has pulled back about 7% since the quarter, creating an opportunity to upgrade our rating to a 1 . Although it’s unconventional to buy a retail stock when there are warning signs about consumer spending, TJX is the best-operated off-price retailer and could potentially benefit from all this with shoppers increasingly looking for quality merchandise at value prices. In addition, TJX historically benefits whenever there are supply chain disruptions, which tariffs and unclear trade policy can create. If a retailer rushes orders to try to get ahead of tariffs and doesn’t…
Read More: We are booking profits in a rallying rotation play and buying 2 others on